Month: July 2024

1917 posts
COOFANDY Showcases Global Vision at the 10th Bonjour Brand Forum 2024

COOFANDY Showcases Global Vision at the 10th Bonjour Brand Forum 2024

PARIS, July 2, 2024 /PRNewswire/ — COOFANDY, the modern men’s essentials designer…
LG Energy Solution to Supply LFP EV Batteries to Renault Group's Ampere

LG Energy Solution to Supply LFP EV Batteries to Renault Group's Ampere

LG Energy Solution to supply lithium iron phosphate (LFP) pouch-type batteries to…
Eye Level Malaysia Celebrates 20 Years of Excellence in Education

Eye Level Malaysia Celebrates 20 Years of Excellence in Education

KUALA LUMPUR, Malaysia, July 2, 2024 /PRNewswire/ — Eye Level Malaysia, a…
AGX by Hydra X Launches: Facilitating Cross-Listings for Tokenized Assets

AGX by Hydra X Launches: Facilitating Cross-Listings for Tokenized Assets

SINGAPORE, July 2, 2024 /PRNewswire/ — AGX, a digital exchange operated by…
New Kalibrr Feature: Hybrid Jobs

New Kalibrr Feature: Hybrid Jobs

After the pandemic ended, the world slowly transitioned back to how it…
Cicada Innovations calls for systems approach to 'turbocharge' Future Made in Australia act, announces Tech23 cohort

Cicada Innovations calls for systems approach to 'turbocharge' Future Made in Australia act, announces Tech23 cohort

SYDNEY, July 2, 2024 /PRNewswire/ — Australia’s flagship deep tech incubator Cicada…
Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, July 2, 2024 /PRNewswire/ — Innovent Biologics,…